Craft
Chiesi Group

Chiesi Group

Revenue

€2.4 B

Y, 2021

Chiesi Group Summary

Company summary

Overview
Chiesi Group (Gruppo Chiesi, also known as Chiesi Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. It focuses on respiratory, neonatology, rare disease, and special care areas. In addition, the company specializes in drug discovery, preclinical research, manufacturing controls, clinical development, regulatory affairs, pharmacovigilance, etc.
Type
Subsidiary
Status
Active
Founded
1935
HQ
Parma, IT | view all locations
Website
https://www.chiesi.com/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Ugo Di Francesco

    Ugo Di Francesco, CEO and Director

  • Alessandro Carloni

    Alessandro Carloni, Chief Financial Officer

  • Alessandro Chiesi

    Alessandro Chiesi, Chief Commercial Officer and Director

    • Giacomo Mazzariello

      Giacomo Mazzariello, Chief Human Resources Officer

    Operating MetricsView all

    Commercial Distributors

    75

    Y, 2021

    Active Research Studies

    49

    Y, 2020

    Partners and Suppliers

    19K
    18.8%

    Y, 2021

    LocationsView all

    39 locations detected

    • Parma, Emilia-Romagna HQ

      Italy

      Via Palermo, 26A

    • Boston, MA

      United States

      One Boston Place, Suite 4000

    • Cary, NC

      United States

      1255 Crescent Green # 250

    • Cary, NC

      United States

      175 Regency Woods #600

    • Melbourne, VIC

      Australia

      Suite 3, 22 Gillman Street

    • Wien, Wien

      Austria

      Gonzagagasse 16/16

    and 33 others

    Chiesi Group Financials

    Summary financials

    Revenue (Y, 2021)
    €2.4B

    Footer menu